申请人:Priepke Henning
公开号:US20120309738A1
公开(公告)日:2012-12-06
This invention relates to compounds of formula I
their use as inhibitors of the microsomal prostaglandin E
2
synthase-1 (mPGES-1), to pharmaceutical compositions containing them, and their use as medicaments for the treatment and/or prevention of inflammatory diseases and associated conditions. A, M, W, R
1
, R
2
, R
3
, R
4
, R
6
, R
2
, R
7
, R
8
, R
9
, R
a
, R
b
have meanings given in the description.
这项发明涉及公式I化合物,它们作为微粒体前列腺素E2合酶-1(mPGES-1)的抑制剂的用途,含有它们的药物组合物,以及它们作为治疗和/或预防炎症性疾病和相关症状的药物的用途。A、M、W、R1、R2、R3、R4、R6、R2、R7、R8、R9、Ra、Rb在描述中有给定的含义。